Recombinant Human PRMT5 Protein, His (Fc)-Avi-tagged
Cat.No. : | PRMT5-1771H |
Product Overview : | Recombinant Human PRMT5 with His (Fc)-Avi tag was expressed and purified |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Human |
Tag : | His&Fc&Avi |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method |
Purity : | ≥85% by SDS-PAGE |
Stability : | Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Storage : | For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
Storage Buffer : | PBS buffer |
Gene Name : | PRMT5 protein arginine methyltransferase 5 [ Homo sapiens (human) ] |
Official Symbol : | PRMT5 |
Synonyms : | HSL7; JBP1; SKB1; IBP72; SKB1Hs; HRMT1L5 |
Gene ID : | 10419 |
mRNA Refseq : | NM_006109.5 |
Protein Refseq : | NP_006100.2 |
MIM : | 604045 |
UniProt ID : | O14744 |
Products Types
◆ Recombinant Protein | ||
PRMT5-7125M | Recombinant Mouse PRMT5 Protein, His (Fc)-Avi-tagged | +Inquiry |
Prmt5-5133M | Recombinant Full Length Mouse Prmt5 Protein, Myc/DDK-tagged | +Inquiry |
PRMT5-3432R | Recombinant Rhesus Macaque PRMT5 Protein, His (Fc)-Avi-tagged | +Inquiry |
PRMT5-3004H | Recombinant Human PRMT5 Protein, MYC/DDK-tagged | +Inquiry |
PRMT5-1969H | Recombinant Human PRMT5, GST-tagged | +Inquiry |
◆ Lysates | ||
PRMT5-2577HCL | Recombinant Human PRMT5 cell lysate | +Inquiry |
◆ Assay kits | ||
Kit-1859 | PRMT5 Homogeneous Assay Kit | +Inquiry |
Kit-1858 | PRMT5 Chemiluminescent Assay Kit | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewGreat performance in ELISA.
Its purity and functionality ensure precise and reproducible results, enabling me to achieve my research objectives with confidence.
The PRMT5 protein demonstrates exceptional quality, making it an ideal candidate to fulfill my experimental requirements.
Q&As (5)
Ask a questionYes, there are ongoing clinical trials investigating the efficacy of PRMT5 inhibitors in various cancer types.
PRMT5 influences cellular differentiation by regulating the expression of genes involved in the process.
Yes, there is interest in exploring combination therapies involving PRMT5 inhibitors with other anticancer agents to enhance treatment efficacy.
PRMT5 methylates histone proteins, leading to changes in chromatin structure and gene expression, thus playing a crucial role in epigenetic regulation.
PRMT5 has been implicated in neurodegenerative diseases, and understanding its role may provide insights into developing therapies for conditions like Alzheimer's and Parkinson's disease.
Ask a Question for All PRMT5 Products
Required fields are marked with *
My Review for All PRMT5 Products
Required fields are marked with *
Inquiry Basket